Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ11241127-2,00
KB119311950,08
PKN109,06109,120,70
Msft-0,13
Nokia5,9565,960,91
IBM1,10
Mercedes-Benz Group AG57,3857,39-0,40
PFE0,40
16.02.2026 11:23:59
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Apyx Medical Rg (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
3,72 -2,62 -0,10 115 490
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.02.2026
Popis společnosti
Obecné informace
Název společnostiApyx Medical Inc
TickerAPYX
Kmenové akcie:Ordinary Shares
RICAPYX.O
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 220
Akcie v oběhu k 19.11.2025 41 014 254
MěnaUSD
Kontaktní informace
Ulice5115 Ulmerton Road
MěstoCLEARWATER
PSČ33760
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 273 842 323
Fax16314215821

Business Summary: Apyx Medical, Inc., formerly Apyx Medical Corporation, is a surgical aesthetics company. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Apyx Medical Inc revenues decreased 1% to $33.7M. Net loss decreased 47% to $9.9M. Revenues reflect OEM segment decrease of 31% to $5.1M, International segment decrease of 6% to $9.8M. Lower net loss reflects Advance Energy segment income totaling $2.6M vs. loss of $5.1M, Corporate (other) segment loss decrease of 19% to $10M.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSElectrical Apparatus and Equipment, Wiring Supplies, and Related Equipment Merchant Wholesalers
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICMedical And Hospital Equipment
SICElectrical Apparatus/equipment



  • Poslední aktualizace: 16.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorCharles Goodwin5915.12.201715.12.2017
Chief Financial Officer, Treasurer, SecretaryMatthew Hill5604.12.202304.12.2023
Chief Operating OfficerShawn Roman5406.11.202406.11.2024
Senior Vice PresidentMoshe Citronowicz72